These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7053268)

  • 61. Phase II trial of methyl-GAG (NSC-32946) in squamous cell and adenocarcinoma of the lung.
    Samson MK; Baker LH; Cummings G; Talley RW
    Am J Clin Oncol; 1982 Dec; 5(6):631-3. PubMed ID: 7165005
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pharmacokinetic profile of Mitoguazone (MGBG) in patients with AIDS related non-Hodgkin's lymphoma.
    Rizzo J; Levine AM; Weiss GR; Pearce T; Kraynak M; Mueck R; Smith S; Von Hoff DD; Kuhn JG
    Invest New Drugs; 1996; 14(2):227-34. PubMed ID: 8913846
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Mitoguazone (methylglyoxal bis(guanylhydrazone))--its status and prospects].
    Hoffmann H; Gutsche W; Amlacher R; Schulze W; Werner W; Lenk H; Wohlrab W; Haupt E
    Arch Geschwulstforsch; 1989; 59(2):135-48. PubMed ID: 2655552
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Combination therapy with 5-azacytidine (NSC-102816) and methyl-GAG (NSC-32946) in previously treated adults with acute nonlymphocytic leukemia.
    Levi JA; Wiernik PH
    Cancer Chemother Rep; 1975; 59(5):1043-5. PubMed ID: 54215
    [No Abstract]   [Full Text] [Related]  

  • 65. Dialyzability of methyl-GAG.
    Jensen B; Williams RD; Ohnuma T; Roboz J
    Cancer Treat Rep; 1983 Mar; 67(3):283-4. PubMed ID: 6831474
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Phase II trial of methylglyoxal-bis-guanylhydrazone (methyl-GAG) in patients with soft-tissue sarcomas.
    Sordillo PP; Magill GB; Welt S
    Am J Clin Oncol; 1985 Aug; 8(4):316-8. PubMed ID: 3909804
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Phase I study of elliptinium (2-N-methyl-9-hydroxyellipticinium).
    Einzig AI; Gralla RJ; Leyland-Jones BR; Kelsen DP; Cibas I; Lewis E; Greenberg E
    Cancer Invest; 1985; 3(3):235-41. PubMed ID: 4005651
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Phase II study of mitoguazone in pancreatic cancer: a Southwest Oncology Group Study.
    Inamasu MS; Oishi N; Chen TT; Kraut EH; Grozea PN; Costanzi JJ; Bonnet JD
    Cancer Treat Rep; 1986 Apr; 70(4):531-2. PubMed ID: 3698049
    [No Abstract]   [Full Text] [Related]  

  • 69. Phase II trial of mitoguazone in children with leukemia and lymphoma: a Pediatric Oncology Group Study.
    Kinney TR; Krischer JP; Starling KA; Alvarado C; Kamen B
    Cancer Treat Rep; 1986 Aug; 70(8):1041-2. PubMed ID: 3524835
    [No Abstract]   [Full Text] [Related]  

  • 70. Mucocutaneous side effects of Brequinar sodium. A new inhibitor of pyrimidine de novo biosynthesis.
    Schwartsmann G; Bork E; Vermorken JB; Nieboer C; Dodion P; ten Bokkel Huinink WW; Seldenrijk CA; Armand JP; Pinedo HM
    Cancer; 1989 Jan; 63(2):243-8. PubMed ID: 2521297
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Antineoplastic effect of 1,4-benzoquinone guanylhydrazone thiosemicarbazone in experimental tumor models].
    Fichtner I; Arnold W
    Pharmazie; 1983 Feb; 38(2):130-1. PubMed ID: 6856663
    [No Abstract]   [Full Text] [Related]  

  • 72. Hypoglycemia: not an important side effect of mitoguazone.
    Foster BJ; Clagett-Carr K; O'Dwyer PJ; Leyland-Jones B
    Cancer Treat Rep; 1985 Nov; 69(11):1340. PubMed ID: 4092202
    [No Abstract]   [Full Text] [Related]  

  • 73. Phase I--II trial of methyl-GAG in the treatment of patients with metastatic renal adenocarcinoma.
    Todd RF; Garnick MB; Canellos GP; Richie JP; Gittes RF; Mayer RJ; Skarin AT
    Cancer Treat Rep; 1981; 65(1-2):17-20. PubMed ID: 7226167
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Phase II study of methyl-GAG in the treatment of esophageal carcinoma.
    Kelsen D; Chapman R; Bains M; Heelan R; Dukeman M; Golbey R
    Cancer Treat Rep; 1982 Jun; 66(6):1427-9. PubMed ID: 7083245
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Phase II trial of methyl-G (methylglyoxal bis-guanylhydrazone) in patients with metastatic renal cell carcinoma.
    Fuks JZ; Van Echo DA; Aisner J; Mitchell EP; Woolley PV; Wiernik PH
    Cancer Clin Trials; 1981; 4(4):411-4. PubMed ID: 7318123
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Treatment of patients with upper gastrointestinal carcinomas.
    Ajani JA
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-72-S19-76. PubMed ID: 9427271
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Methyl-GAG in patients with malignant neoplasms: a phase I re-evaluation.
    Hart RD; Ohnuma T; Holland JF; Bruckner H
    Cancer Treat Rep; 1982 Jan; 66(1):65-71. PubMed ID: 7053268
    [TBL] [Abstract][Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.